跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 32,529 条关于
“Activated PI3K Delta Syndrome”
全部
32,529
临床试验
27,238
药物
1,123
机构
46
资讯
4,122
3个月前
Patient Voices Are Redefining Rare Disease Innovation, Say Biotech Leaders
2年前
TC BioPharm to Explore Gamma Delta T-Cell Therapy TCB008 for Mpox Treatment
11个月前
Novel RAS-PI3K Inhibitor Enters Clinical Trials, Targeting Cancer Growth Without Metabolic Side Effects
去年
Paxalisib, TTFields, and Proton Irradiation Show Promise in Neuro-oncology
10个月前
IN8bio's Novel Gamma-Delta T Cell Engager Shows Promise for Autoimmune Disease Treatment
去年
STX-478 Shows Promise as Mutant-Selective PI3Kα Inhibitor in Solid Tumors
去年
Pharming Group Initiates Phase II Trial of Leniolisib for Primary Immunodeficiencies
7个月前
Pharming Advances Rare Disease Pipeline with Napazimone for Mitochondrial Disease and Leniolisib Expansion
上个月
Light-Activated Nanorobots Enable Targeted Phototherapy for Breast Cancer
去年
Aspirin Reduces Colorectal Cancer Recurrence in PI3K-Mutated Tumors
第 1 页，共 413 页
上一页
下一页
